Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony J Olszanski

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Journal of Managed Care & Specialty Pharmacy|April 2, 2014
Current and future roles of targeted therapy and immunotherapy in advanced melanomaAnthony J Olszanski
Journal of the National Comprehensive Cancer Network : JNCCN|May 23, 2019
Mutation Testing and Adjuvant Systemic Therapy in Cutaneous MelanomaAnthony J Olszanski
Journal of the National Comprehensive Cancer Network : JNCCN|May 22, 2015
Principles of immunotherapyAnthony J Olszanski
Journal of the Advanced Practitioner in Oncology|February 18, 2021
Immune Checkpoint Inhibitor-Based Therapy as a Backbone in Cancer TreatmentKrista M Rubin, Anthony J Olszanski
Pharmaceutical Medicine|March 12, 2020
Addressing Recent Failures in Immuno-Oncology Trials to Guide Novel Immunotherapeutic Treatment StrategiesShazia K Nakhoda, Anthony J Olszanski
Journal of the Advanced Practitioner in Oncology|February 18, 2021
Creating Clarity in Metastatic Melanoma: Optimizing Treatment and Improving OutcomesAmanda M Viereck, Anthony J Olszanski
Journal of the National Comprehensive Cancer Network : JNCCN|May 25, 2013
Progress in the management of melanoma in 2013Daniel G Coit, Anthony J Olszanski
Journal for Immunotherapy of Cancer|February 18, 2016
Autoimmune inner ear disease in a melanoma patient treated with pembrolizumabMatthew Zibelman, Natasha Pollak, Anthony J Olszanski
Journal of the Advanced Practitioner in Oncology|June 22, 2018
Advances in the Use of Immunotherapy in OncologyAnthony J Olszanski, Laura J Zitella
Expert Opinion on Drug Metabolism & Toxicology|January 18, 2012
Pharmacokinetic evaluation of axitinibBrian Patson, Roger B Cohen, Anthony J Olszanski
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Journal of Managed Care & Specialty Pharmacy|April 2, 2014
Current and future roles of targeted therapy and immunotherapy in advanced melanomaAnthony J Olszanski
Journal of the National Comprehensive Cancer Network : JNCCN|May 23, 2019
Mutation Testing and Adjuvant Systemic Therapy in Cutaneous MelanomaAnthony J Olszanski
Journal of the National Comprehensive Cancer Network : JNCCN|May 22, 2015
Principles of immunotherapyAnthony J Olszanski
Journal of the Advanced Practitioner in Oncology|February 18, 2021
Immune Checkpoint Inhibitor-Based Therapy as a Backbone in Cancer TreatmentKrista M Rubin, Anthony J Olszanski
Pharmaceutical Medicine|March 12, 2020
Addressing Recent Failures in Immuno-Oncology Trials to Guide Novel Immunotherapeutic Treatment StrategiesShazia K Nakhoda, Anthony J Olszanski
Journal of the Advanced Practitioner in Oncology|February 18, 2021
Creating Clarity in Metastatic Melanoma: Optimizing Treatment and Improving OutcomesAmanda M Viereck, Anthony J Olszanski
Journal of the National Comprehensive Cancer Network : JNCCN|May 25, 2013
Progress in the management of melanoma in 2013Daniel G Coit, Anthony J Olszanski
Journal for Immunotherapy of Cancer|February 18, 2016
Autoimmune inner ear disease in a melanoma patient treated with pembrolizumabMatthew Zibelman, Natasha Pollak, Anthony J Olszanski
Journal of the Advanced Practitioner in Oncology|June 22, 2018
Advances in the Use of Immunotherapy in OncologyAnthony J Olszanski, Laura J Zitella
Expert Opinion on Drug Metabolism & Toxicology|January 18, 2012
Pharmacokinetic evaluation of axitinibBrian Patson, Roger B Cohen, Anthony J Olszanski
Pageof 9